Table 5 circRNAs and prognosis of breast cancer
From: circRNAs and their relationship with breast cancer: a review
CircRNA | Expression in BC | Subtype of BC | Sample | Survival | P value | HR (95%CI) | Number of cases | Ref. |
|---|---|---|---|---|---|---|---|---|
circANKS1B | ↑ | – | Tissue | OS | 0.002 | 3.29 (1.75–8.23) | 165 | [32] |
circCDYL | ↑ | – | Tissue | DFS | 0.0036 | 2.85 (1.415–5.739) | 113 | [57] |
MBC | Serum | OS | 0.002 | 3.748 (1.233–11.239) | 30 | |||
circAGFG1 | ↑ | TNBC | Tissue | OS | < 0.0001 | – | 80 | [33] |
circKIF4A | ↑ | TNBC | Tissue | DFS, OS | < 0.01 | – | 240 | [73] |
circFBXW7 | ↑ | TNBC | Tissue | OS | 0.001 | 0.215 (0.119–0.387) | 473 | [81] |
circ_0001073 | ↓ | – | Tissue | RFS | 0.038 | – | 132 | [78] |